The Research and Development team at eTheRNA focuses on advancing cutting-edge immuno-oncology therapies by integrating expertise in clinical and product development, pharmacology, and bioinformatics. They collaboratively design, test, and optimize messenger RNA formulations and analytical methods to ensure the efficacy and safety of innovative treatments aimed at activating antigen-presenting cells.
View all